RecruitingNCT03099681
An Observational Study on Epithelioid Sarcoma
Epithelioid Sarcoma. An Observational Study
Sponsor
Italian Sarcoma Group
Enrollment
100 participants
Start Date
Aug 22, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective Italian study aimed to provide a description of the population affected by Epithelioid Sarcoma (ES)
Eligibility
Inclusion Criteria4
- Histological diagnosis of epithelioid sarcoma according to 2014 World Health Organization (WHO) classification, performed on biopsy or surgical specimen
- Signed informed consent
- Adequate patient compliance to treatment or follow up
- No age limit
Exclusion Criteria2
- Other malignancies within past 5 years, with exception of carcinoma in situ of the cervix and basocellular skin cancers treated with eradicating intent
- Impossibility to ensure adequate compliance
Interventions
OTHERTreatment for Epitheloid Sarcoma
Treatment Epitheloid Sarcoma according the disease guideline
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03099681
Related Trials
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
NCT066251901 location
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
NCT0396783420 locations
Evaluate the Safety and Clinical Activity of HH2853
NCT0439073725 locations
Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
NCT054074413 locations
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
NCT062771541 location